Labrador Health

Labrador Health

The future of healthcare is preventive care.

HQ location
United States
Launch date
Employees
Enterprise value
$400—600k
  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round
investor

€0.0

round
*

N/A

Acquisition
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
USD2023
Revenues0000
EBITDA0000
Profit0000
EV0000
EV / revenue00.0x
EV / EBITDA00.0x
R&D budget0000

Source: Dealroom estimates

Notes (0)
More about Labrador Health
Made with AI
Edit

Labrador Health was established in 2021 by CEO Yoav Kessler, PhD, and repeat entrepreneur and investor Amit Avner. The company focuses on preventative care by developing diagnostic tools that aim to provide a more comfortable and accessible testing experience for early detection of chronic conditions.

The core of Labrador Health's offering was a platform designed for quantitative urine testing that could be performed at home. This system integrated proprietary biochemistry, microfluidics, and computer vision technologies to deliver lab-grade results using a smartphone. The initial focus of this technology was on early screening for pre-diabetes to facilitate timely treatment and prevent the progression to chronic disease. The company had engaged in partnerships with clinical institutions to validate its solutions.

In August 2021, the firm secured $5 million in a Seed funding round. Notable investors included Vast Ventures, Box Group, and Kli Capital, alongside prominent angel investors from the health and tech industries, such as the co-founders of Flatiron Health and Plaid. A significant milestone occurred in April 2025, when Labrador Health was acquired by Healthy.io, a company that transforms smartphone cameras into clinical-grade diagnostic tools. Following the acquisition, the entire Labrador Health team joined Healthy.io to integrate their technologies. The combined effort is focused on developing the first quantitative, at-home albumin-to-creatinine ratio (ACR) test for monitoring kidney health, which is anticipated to launch in 2026.

Keywords: at-home diagnostics, quantitative testing, preventative care, urine testing, computer vision diagnostics, microfluidics, early disease detection, chronic kidney disease, pre-diabetes screening, Healthy.io acquisition, Yoav Kessler, Amit Avner, home testing platform, ACR test, smartphone diagnostics, health-tech, medical diagnostics, remote patient monitoring

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads